|
參考文獻 1. 交大生物科技資訊網(http://biotech.life.nctu.edu.tw). 2001. 濫用抗生素2病菌抗藥性冠全國. 2. Hiramatsu K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [see comments]. Lancet. 350:1670-1673. 3. Hanaki H. Y. Inaba, K. Sasaki and K.Hiramatsu. 1998. A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA). Japanese Journal of Antibiotics. 51:521-30. 4. Hanaki H., H. Labischinski, Y. Inaba, N. Kondo, H. Murakami and K. Hiramatsu. 1998. Increase inglutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. Journal of Antimicrobial Chemotherapy. 42:315-320. 5. Hanaki H, K. Kuwahara-Arai, S. Boyle-Vavra, R. S. Daum, H. Labischinski, and K. Hiramatsu. 1998. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. Journal of Antimicrobial Chemotherapy. 42:199-209. 6. Hanaki H., H. Labischinski, Y. Inaba and K. Hiramatsu. 1998. Increase of non-amidatedmuropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50. Japanese Journal of Antibiotics. 51:272-80. 7. Bliss, C. F. 1939. The toxicity of poisons applied jointy. Ann. Appl. Biol. 26:585-591. 8. Hewlett, P. S. and R. L. Plankett. 1959. A united theory for quantal responses to mixtures of drugs: non-interactive action. Biometrics. 15: 91-610. 9. Christensen, E. R. and C. Y. Chen. 1985. A general noninteractive multiple toxicity model including Probit, Logit, and Weibull transformations. Biometrics. 41:711-725. 10. Christensen, E. R. and C. Y. Chen. 1991. Modeling of combined toxic effects of chemicals. Toxic Substance Journal. 11:1-63. 11. Loewe, S. and H. Muischnek. 1926. Yber kombinattonswirkungan 1. mitteilung: Hilfsmittel der fragestellung naunyn-schmledebergs. ,Arch Exp.Pathol. Pharmakol. 114:313-326. 12. Sprague, J. B. and B. A. Ramsay. 1965. Lethal levels of mixed copper-zine solution for juvenile salmo. J. Fish. Res. Bd. Can. 22:425-432. 13. Marking, L. L. 1977. Method for assessing additive toxicity of chemical mixture, auqatic toxicology and hazard evaluation. ASTM STP Publication. 634:99-208. 14. Konemann, H. 1981a. Fish toxicity tests with mixtures of more than two chemicals; a proposal for a quantitative approach and experimental results. Toxicology. 19: 229-238. 15. Konemann, H. 1981b. Quantitative structure-activity relationships in fish toxicity studies, Part I: Relationship for 50 industrial pollutants. Toxicology. 19: 209-221. 16. Chang, S. C., W. C. Hsieh, K. T. Luh and S. W. Ho. 1989. Effects of antibiotic combinations on methicillin-resistant Staphylococcus aureus in vitro. Formosan Med Assoc. 88:488-492. 17. Matsuda K., Y. Asahi, M. Sanada, S. Nakagawa, N. Tanaka and M. Inoue. 1991. In-vitro activity of impenem combination with β-lactam antibiotics for methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 27:809-815. 18. Komatsuzawa, H. J. Suzuki, M. Sugai, Y. Miyake and H. Suginaka. 1994. Effect of combination of oxacillin and non-β-lactam antibiotics on methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 33:1155-1163. 19. Kang, S. L. and M. J. Rybak. 1995. Pharmacodynamics of RP59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model. Antimicrobial Agents and Chemotherapy. 39:1505-1511. 20. Mulazimoglu, L., S. D. Drenning and R. R. Muder. 1996. Vancomycin — gentamicin synergism revisited: effect of gentamicin susceptibility of methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 40:1534-1535. 21. Ferrara, A., C. D. Santos, M. Cimbro and G. G. Grassi. 1997. Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 16:535-537. 22. Plamer, S. M. and M. J. Rybak. 1997. An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots. Journal of Antimicrobial Chemotherapy. 39:515-518. 23. Dinesh Bahl, Doroyhy A. Miller, Ira Leviton, Philip Gialanella, Meyer J. Wolin, Weiguo Liu, Ruth Perkinns and Michael H. Miller. 1997. In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 41:1293-1297. 24. Sambatakou, H., E. J. Giamarellos-Bourboulis, P. G. Z. Chryssouli and H. Giamarellou. 1998. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates. Journal of Antimicrobial Chemotherapy. 41:349-355. 25. Sakagami, Y., M. Mimura, K. Kajimura, H. Yokoyama, M. Linuma, T. Tanaka and M. Ohyama. 1998. Anti-MRSA activity of sophoraflavanone G and synergism with other antibacterial agents. Letters in Applied Microbiology. 27:98-100. 26. Bag Kumar Gang, Suhas C. Sanyal, Eliman Mokaddas and Abdul Reda Lari. 1999. Rifampin as an adjunct to vancomycin therapy in MRSA septicaemia in burns. Burns. 25:640-644. 27. Beth E. Domaracki, Ann M. Evana and Richard A. Venezia. 2000. Vancomycin and oxacillin synergy for methicillin-resistant Staphylococci. Antimicrobial Agents and Chemotherapy. 44:1394-1396. 28. Jefferey R. Aeschlimann, George P. Allen, Ellie Hershberger and Michael J. Rybak. 2000. Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an vitro pharmacodynamic infection model. Antimicrobial Agents and Chemotherapy. 44:2991-2998. 29. Stephanie Rochon-Edouard, Martine Pestel-Caron, Jean-Francois Lemeland and Francois Caron. 2000. In vitro synergistic effects of double and triple combinations of β-lactams, vancomycin and netilmicin against methicillin-resistant Staphylococcus aureus strains. 44:3055-3060. 30. Narae Aritaka, Hideaki Hanaki, Longzhu Cui and Keiichi Hiramatsu. 2001. Combination effect of vancomycin and β-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrobial Agents and Chemotherapy. 45:1292-1294. 31. Wei-Hua Zhao, Zhi-Qing Hu, Sachie Okubo, Yukihiko Hara and Tadakatsu Shimamura. 2001. Mechanism of synergy between Epigallocatechinn Gallate and β-lactams against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 45:1737-1742. 32. Peter C. Fuchs, Arthur L. Barry and Steven D. Brown. 2001. Interactions of quinupristin-dalforpristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalforpristin alone was not bactericidal. Antimicrobial Agents and Chemotherapy. 45:2662-2665. 33. Christensen, E. R. 1984. Dose-response functions in aquatic toxicity testing and the Weibull model. Water Res. 18:213-221. 34. Christensen, E. R., and C. Y. Chen. 1985. A general noninteractive multiple toxicity model including probit, logit, and weibull transformations. Biometrics. 41:711-725. 35. Christensen, E. R. and C. Y. Chen. 1986. MULTOX, a computer program for the calculation of response of organisms to multiple toxicants and multiple limiting nuturients. AEEP’s Computer Manual. pp. 166-173. 36. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved Standard M7-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa. 37. National Committee for Clinical Laboratory Standards. 1992. Methods for determining bactericidal activity of antimicrobial agents. Document M26-T. National Committee for Clinical Laboratory Standards, Wayne, Pa.
|